7 days | +2.98% | +0.98% | -1.14% |
1 month | -4.2% | -3.02% | -2.65% |
6 months | +0.61% | -7.58% | +7.33% |
1 year | +48.25% | -2.21% | +19.01% |
Buys | $13,289,410 | 3 | 3 |
Sells | $94,289,560 | 95 | 97 |
RA CAPITAL MANAGEMENT, L.P. | 90 | $398.68M | 0 | $0 | $398.68M | |
Scott Kathleen D. | Chief Financial Officer | 0 | $0 | 2 | $400,000 | $-400,000 |
Karas Eric | Chief Commercial Officer | 0 | $0 | 4 | $420,423 | $-420,423 |
Dorsey Brian | Chief Operating Officer | 0 | $0 | 4 | $1.63M | $-1.63M |
Shawver Laura | director | 0 | $0 | 4 | $3.24M | $-3.24M |
Chakma Justin | Chief Business Officer | 0 | $0 | 11 | $7.09M | $-7.09M |
Lowenthal Richard E | PRESIDENT AND CEO | 0 | $0 | 30 | $23.09M | $-23.09M |
Tanimoto Sarina | CHIEF MEDICAL OFFICER | 0 | $0 | 30 | $23.09M | $-23.09M |
Thompson Peter A. | director | 0 | $0 | 24 | $75.52M | $-75.52M |
Flynn James E | 10 percent owner | 0 | $0 | 76 | $385.46M | $-385.46M |
ORBIMED ADVISORS LLC | director | 0 | $0 | 168 | $528.61M | $-528.61M |
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Over the last 12 months, insiders at ARS Pharmaceuticals, Inc. have bought $13.29M and sold $94.29M worth of ARS Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at ARS Pharmaceuticals, Inc. have bought $25.62M and sold $32.63M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $398.68M.
The last purchase of 505,954 shares for transaction amount of $4.95M was made by RA CAPITAL MANAGEMENT, L.P. () on 2024‑03‑27.
2025-01-06 | Sale | Shawver Laura | director | 50,000 0.0511% | $11.10 | $555,065 | +2.35% | |
2024-12-17 | Sale | Tanimoto Sarina | CHIEF MEDICAL OFFICER | 100,000 0.1035% | $11.67 | $1.17M | -5.48% | |
2024-12-17 | Sale | Lowenthal Richard E | PRESIDENT AND CEO | 100,000 0.1035% | $11.67 | $1.17M | -5.48% | |
2024-12-13 | Sale | Chakma Justin | Chief Business Officer | 27,272 0.0282% | $12.06 | $328,969 | -6.18% | |
2024-12-12 | Sale | Chakma Justin | Chief Business Officer | 117,333 0.1186% | $12.27 | $1.44M | -11.55% | |
2024-12-12 | Sale | Dorsey Brian | Chief Operating Officer | 25,000 0.0253% | $12.30 | $307,433 | -11.55% | |
2024-12-11 | Sale | Dorsey Brian | Chief Operating Officer | 15,000 0.0154% | $12.43 | $186,426 | -8.84% | |
2024-12-10 | Sale | Tanimoto Sarina | CHIEF MEDICAL OFFICER | 100,000 0.1038% | $13.16 | $1.32M | -13.59% | |
2024-12-10 | Sale | Lowenthal Richard E | PRESIDENT AND CEO | 100,000 0.1038% | $13.16 | $1.32M | -13.59% | |
2024-12-10 | Sale | Chakma Justin | Chief Business Officer | 50,000 0.0519% | $13.15 | $657,625 | -13.59% | |
2024-12-06 | Sale | Chakma Justin | Chief Business Officer | 50,000 0.0517% | $14.23 | $711,615 | -20.11% | |
2024-12-05 | Sale | Chakma Justin | Chief Business Officer | 49,640 0.0521% | $14.13 | $701,642 | -19.50% | |
2024-12-04 | Sale | Shawver Laura | director | 14,772 0.0146% | $13.75 | $203,109 | -21.36% | |
2024-12-04 | Sale | Chakma Justin | Chief Business Officer | 45,000 0.0452% | $13.95 | $627,944 | -21.36% | |
2024-12-04 | Sale | Karas Eric | Chief Commercial Officer | 6,283 0.0063% | $14.00 | $87,962 | -21.36% | |
2024-12-03 | Sale | Shawver Laura | director | 87,984 0.0888% | $13.26 | $1.17M | -15.14% | |
2024-12-03 | Sale | Chakma Justin | Chief Business Officer | 45,000 0.0452% | $13.19 | $593,402 | -15.14% | |
2024-12-02 | Sale | Shawver Laura | director | 97,244 0.1019% | $13.56 | $1.32M | -11.71% | |
2024-12-02 | Sale | Chakma Justin | Chief Business Officer | 45,000 0.0475% | $13.67 | $615,218 | -11.71% | |
2024-12-02 | Sale | Karas Eric | Chief Commercial Officer | 3,717 0.0041% | $14.11 | $52,461 | -11.71% |
RA CAPITAL MANAGEMENT, L.P. | 9958073 10.2465% | $11.42 | 5 | 0 | +131.88% | |
ORBIMED ADVISORS LLC | director | 0 0% | $11.42 | 1 | 4 | |
Thompson Peter A. | director | 0 0% | $11.42 | 1 | 4 | |
Fitzpatrick Alexander A | Chief Legal Officer | 89227 0.0918% | $11.42 | 2 | 0 | +133.38% |
$9,548,561 | 115 | 42.68% | $1.36B | |
$42,566,043 | 62 | 20.68% | $1.27B | |
$1,100,323,459 | 57 | 37.65% | $1.38B | |
$30,734,139 | 42 | 4.73% | $1.27B | |
$89,002,190 | 39 | 17.92% | $991.52M |